Development of effective tumor immunotherapy using a novel dendritic cell–targeting Toll-like receptor ligand

Although dendritic cell (DC)-based immunotherapy shows little toxicity, improvements should be necessary to obtain satisfactory clinical outcome. Using interferon-gamma injection along with DCs, we previously obtained significant clinical responses against small or early stage malignant tumors in do...

Descripción completa

Detalles Bibliográficos
Autores principales: De Silva, Nadeeka H., Akazawa, Takashi, Wijewardana, Viskam, Inoue, Norimitsu, Oyamada, Maremichi, Ohta, Atsuko, Tachibana, Yuki, Wijesekera, Daluthgamage Patsy H., Kuwamura, Mitsuru, Nishizawa, Yasuko, Itoh, Kazuyuki, Izawa, Takeshi, Hatoya, Shingo, Hasegawa, Tetsuya, Yamate, Jyoji, Inaba, Toshio, Sugiura, Kikuya
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2017
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5708771/
https://www.ncbi.nlm.nih.gov/pubmed/29190690
http://dx.doi.org/10.1371/journal.pone.0188738

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5708771/
https://www.ncbi.nlm.nih.gov/pubmed/29190690
http://dx.doi.org/10.1371/journal.pone.0188738

Ejemplares similares